Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox‐Gastaut syndrome

Developmental encephalopathic epilepsies (DEEs) are characterized by refractory seizures, disability, and early death. Opportunities to improve care and outcomes focus on West syndrome/infantile spasms (WS/IS). Lennox‐Gastaut syndrome (LGS) is almost as common but receives little attention. We examined initial presentations of DEEs and their evolution over time to identify risk and indicators of developing LGS.

• Publication year

  2018

• Venue

  Epilepsia

• Publication date

  2018-09-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/epi.14569PMID 30255934PMCID PMC6215498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

  2018cited by this paper
• Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms

  2018cited by this paper
• Getting serious about the early-life epilepsies

  2018cited by this paper
• Quality improvement in neurology: Child neurology quality measure set

  2018cited by this paper
• Infantile Spasms—Have We Made Progress?

  2018cited by this paper
• Study of Intraventricular Cerliponase Alfa for CLN2 Disease

  2018cited by this paper
• Incidence and Prevalence of Childhood Epilepsy: A Nationwide Cohort Study

  2017cited by this paper
• Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations

  2017cited by this paper
• Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome.

  2017influential reference
• Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel.

  2017cited by this paper
• Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.

  2017cited by this paper
• Profile of neonatal epilepsies

  2017cited by this paper
• KCNQ2 encephalopathy

  2016cited by this paper
• Response to treatment in a prospective national infantile spasms cohort

  2016cited by this paper
• Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.

  2016cited by this paper
• Epileptic encephalopathy: Use and misuse of a clinically and conceptually important concept

  2016cited by this paper
• Incidence of Dravet Syndrome in a US Population

  2015cited by this paper
• Long-term prognosis of patients with Lennox--Gastaut syndrome in recent decades.

  2015cited by this paper
• Early and effective treatment of KCNQ2 encephalopathy

  2015cited by this paper
• Lennox‐Gastaut syndrome: A consensus approach to differential diagnosis

  2014cited by this paper
• The clinical utility of an SCN1A genetic diagnosis in infantile‐onset epilepsy

  2013cited by this paper
• Report of the Guideline Development Subcommittee of the American Academy of Neurology

  2013cited by this paper
• Evidence-based guideline update: Medical treatment of infantile spasms

  2012cited by this paper
• The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study

  2011cited by this paper
• Strategies for transitioning to adult care for youth with Lennox‐Gastaut syndrome and related disorders

  2011influential reference
• Infantile spasms: A U.S. consensus report

  2010cited by this paper
• Adjunctive rufinamide in Lennox‐Gastaut syndrome: a long‐term, open‐label extension study

  2010cited by this paper
• PRACTICE PARAMETER: EVALUATION OF THE CHILD WITH MICROCEPHALY (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY AND THE PRACTICE COMMITTEE OF THE CHILD NEUROLOGY SOCIETY

  2010cited by this paper
• Towards a modern classification of the epilepsies?

  2010cited by this paper
• Resective Pediatric Epilepsy Surgery in Lennox-Gastaut Syndrome

  2010cited by this paper
• Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology.

  2009cited by this paper
• Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy.

  2009cited by this paper
• Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

  2009cited by this paper
• Global cognitive function in children with epilepsy: A community‐based study

  2008cited by this paper
• Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome

  2008cited by this paper
• Long‐term Prognosis for Symptomatic (Secondarily) Generalized Epilepsies: A Population‐based Study

  2007influential reference
• The Epilepsies: Seizures, Syndromes and Management

  2006cited by this paper
• The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.

  2005cited by this paper
• Epileptic Syndromes in Infancy, Childhood and Adolescence

  2004cited by this paper
• Randomized trial of vigabatrin in patients with infantile spasms.

  2002cited by this paper
• Treatment of infantile spasms: an evidence-based approach.

  2002cited by this paper
• How Well Can Epilepsy Syndromes Be Identified at Diagnosis? A Reassessment 2 Years After Initial Diagnosis

  2000cited by this paper
• Occurrence, Outcome, and Prognostic Factors of Infantile Spasms and Lennox‐Gastaut Syndrome

  1999influential reference
• The Descriptive Epidemiology of Infantile Spasms Among Atlanta Children

  1999cited by this paper
• Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis.

  1999cited by this paper
• Newly Diagnosed Epilepsy in Children: Presentation at Diagnosis

  1999cited by this paper
• Classification of Childhood Epilepsy Syndromes in Newly Diagnosed Epilepsy: Interrater Agreement and Reasons for Disagreement

  1999cited by this paper
• Long‐Term Prognosis of Lennox‐Gastaut Syndrome

  1996cited by this paper
• Incidence of Epilepsy in Childhood and Adolescence: A Population‐Based Study in Nova Scotia from 1977 to 1985

  1996cited by this paper
• Epileptic syndromes in infancy, childhood and adolescence, 2nd edition

  1993cited by this paper
• Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

  1989cited by this paper
• Proposal for Revised Classification of Epilepsies and Epileptic Syndromes

  1989cited by this paper

• Stiripentol: Unpublished results from the first phase 2 clinical trial in Lennox-Gastaut syndrome conducted in the early 1990s.

  2026cites this paper
• Corpus Callosotomy or Focal Surgery in Children Presenting with Generalized Tonic Seizures: Findings from the Pediatric Epilepsy Research Consortium

  2026cites this paper
• Distinct T Cell Dysregulation Reflects Disease Severity and Progression in Infantile Epileptic Spasms Syndrome and Lennox-Gastaut Syndrome

  2025influential citation
• Navigating the Diagnosis: A survey on Caregivers' Journeys to Lennox-Gastaut Syndrome.

  2025cites this paper
• Comparative effectiveness of epilepsy surgery versus additional anti-seizure medications for Lennox–Gastaut syndrome: study protocol for a multicenter, mixed-methods study

  2025cites this paper
• Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies

  2025cites this paper
• Mobilizing a New Era in Lennox-Gastaut Syndrome Treatment and Prevention

  2025cites this paper
• Interictal paroxysmal fast activity and functional connectivity in steroid responsive and non-responsive Lennox-Gastaut syndrome.

  2025cites this paper
• Cenobamate in developmental and epileptic encephalopathies and generalized epilepsies: A case report on epilepsy with myoclonic-atonic seizures and systematic review of current evidence.

  2025cites this paper
• Preclinical Models of Lennox-Gastaut Syndrome: Progress and Priorities

  2025cites this paper
• Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome

  2024cites this paper
• Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches

  2024influential citation
• Discovering EEG biomarkers of Lennox–Gastaut syndrome through unsupervised time–frequency analysis

  2024influential citation
• Clinical trials for Lennox–Gastaut syndrome: Challenges and priorities

  2024cites this paper
• Clinical features and underlying etiology of children with Lennox–Gastaut syndrome

  2024cites this paper
• A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.

  2024cites this paper
• Therapeutic outcome of patients with Lennox–Gastaut syndrome with mitochondrial respiratory chain complex I deficiency

  2024cites this paper
• A comprehensive systematic literature review of the burden of illness of Lennox–Gastaut syndrome on patients, caregivers, and society

  2024cites this paper
• Diagnosis of Lennox-Gastaut syndrome and strategies for early recognition

  2024influential citation
• A systematic literature review on the global epidemiology of Dravet syndrome and Lennox–Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality

  2024influential citation
• Revised Classification and Definition of Epilepsy Syndromes with Onset in Childhood by the International League Against Epilepsy Task Force

  2023cites this paper
• Learnings in developmental and epileptic encephalopathies: what do we know?

  2023cites this paper
• Patient family engagement and partnership: Pilot survey results in assessing behavior, communication, and quality of life in children with Lennox-Gastaut syndrome and other drug-resistant epilepsy.

  2023cites this paper
• Interrater reliability of interictal EEG waveforms in Lennox–Gastaut Syndrome

  2023cites this paper
• Pediatric epilepsy syndromes with associated developmental impairment

  2023cites this paper
• Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children

  2022cites this paper
• Treatment strategies for Lennox-Gastaut syndrome: outcomes of multimodal treatment approaches

  2022cites this paper
• Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.

  2022cites this paper
• International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions

  2022cites this paper
• Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses

  2022cites this paper
• Personalized structural biology reveals the molecular mechanisms underlying heterogeneous epileptic phenotypes caused by de novo KCNC2 variants

  2022cites this paper
• New and emerging pharmacologic treatments for developmental and epileptic encephalopathies

  2022cites this paper
• Development of localized interictal epileptiform discharges following vagus nerve stimulation for lennox-gastaut syndrome: a case report

  2022cites this paper
• Lennox-Gastaut-Syndrom: Wie behandeln?

  2021cites this paper
• Complications and Sequelae in Patients With Congenital Microcephaly Associated With Zika Virus Infection: Two-Year Follow-Up

  2021cites this paper
• Risk factors, etiologies, and comorbidities in urban pediatric epilepsy.

  2021cites this paper
• The Use of Decision Trees for Analysis of the Epilepsy

  2021cites this paper
• Epilepsy Surgery: Special Circumstances.

  2021cites this paper
• Comorbidities in Dravet Syndrome and Lennox–Gastaut Syndrome

  2021cites this paper
• Anti-seizure medications for Lennox-Gastaut syndrome.

  2021cites this paper
• Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials

  2021cites this paper
• Developmental and epileptic encephalopathies: recognition and approaches to care.

  2021cites this paper
• The role of surgery in the management of Lennox–Gastaut syndrome: A systematic review and meta‐analysis of the clinical evidence

  2021cites this paper
• The Biochemical Profile of Post-Mortem Brain from People Who Suffered from Epilepsy Reveals Novel Insights into the Etiopathogenesis of the Disease

  2020cites this paper
• Nonconvulsive status epilepticus in epileptic encephalopathies in childhood.

  2020cites this paper
• Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome

  2020cites this paper
• Immediate outcomes in early life epilepsy: A contemporary account.

  2019cites this paper
• An overview of health issues and development in a large clinical cohort of children with Angelman syndrome

  2019cites this paper